Banff lesions and renal allograft survival in chronic-active antibody mediated rejection.

Abstract

AIMS\nChronic-active antibody mediated rejection (c-aABMR) is a major cause of kidney graft loss. Currently, little is known about the relation between histopathologic parameters and renal allograft survival.\n\n\nMETHODS AND RESULTS\nBetween 2008 and 2014, 41 patients with a progressive decrease in renal function were diagnosed with c-aABMR according to Banff 2015 and followed up for at least 3\u202fyears. Clinical and renal biopsy characteristics were analyzed for association with graft survival. During follow-up 26 cases lost their graft because of c-aABMR at a median follow up of 40\u202fmonths after diagnosis. Cases with v-lesions in their biopsy had a significant higher loss of eGFR prior to diagnosis. The total inflammation score (r\u202f=\u202f-0.45 p\u202f=\u202f.007) and the severity of interstitial fibrosis (r\u202f=\u202f-0.38 p\u202f=\u202f.023) were related to the eGFR at time of biopsy. Univariate regression analysis showed that eGFR at time of biopsy, total inflammation, interstitial fibrosis and the sum chronicity score were significantly related to the risk for graft failure during follow-up. In a multivariate analysis only the severity of interstitial fibrosis remained associated with decreased graft survival (HR 1.9 per score point, 95% CI 1.2-2.8, p\u202f=\u202f.004).\n\n\nCONCLUSION\nSeverity of renal interstitial fibrosis and not inflammation predicts graft survival in cases of c-aABMR.